ARCHIVES

NCI, Komen Foundation Fund Summit meeting On Breast Cancer

This article is from The Cancer Letter archive.

Vol. 19 No. 39 | October 8, 1993

Download PDF Visit The Full Archive

Related Articles

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

NCI-Approved Clinical Trials Listed For April 2001

May 25, 2001

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

May 21, 2004

NCI Advisors Approve Research Network On Screening

August 6, 2010

CyberKnife Delivers 100 Percent PFS at 18.3 Month Followup

January 27, 2012